Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
EDAP
#3093
EDAP TMS SA
4.3
7
-1.80%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-1.80%
Monthly Change
+5.56%
6 month change
+173.12%
Year Change
+65.53%
Previous Close
4.4
5
Open
4.3
7
Bid
Ask
Low
4.3
7
High
4.3
7
Volume
2
Markets
US Stock Market
Healthcare
EDAP
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
TTM
Key stats
Total common shares outstanding
37.39 M
144.87 M
Valuation ratios
Enterprise value
82.64 M
865.47 M
Price to earnings ratio
-4.33
169.85
Price to sales ratio
—
—
Price to cash flow ratio
—
—
Price to book ratio
—
—
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
—
—
Return on equity %
—
—
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
—
—
Current ratio
—
—
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
—
—
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
—
—
Net current asset value per share
—
—
Tangible book value per share
—
—
Working capital per share
—
—
Book value per share
—
—
News
EDAP reports record HIFU revenue, issues strong 2026 guidance
RBOT Enters Strategic Software Partnership to Streamline Development
AngioDynamics: Growth Remains Under The Radar (NASDAQ:ANGO)
EW Wins FDA Approval for SAPIEN M3 as First Transseptal TMVR Therapy
ISRG Gets FDA Clearance to Use da Vinci SP Robot for General Surgeries
EDAP receives FDA clearance for enhanced Focal One robotic HIFU system
EDAP TMS stock price target raised to $2.00 from $1.80 at Jefferies
EDAP earnings beat by €0.08, revenue topped estimates
France approves reimbursement for EDAP’s prostate cancer treatment
EDAP TMS S.A. (EDAP) Q2 2025 Earnings Conference Call Transcript
EDAP earnings beat by €0.01, revenue topped estimates
Earnings call transcript: EDAP TMS Q2 2025 reports revenue growth, stock rises